Annotation Detail for HSPBP1
Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04141 | Protein processing in endoplasmic reticulum |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of HSPBP1 mRNA | affects expression | 21346803
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of HSPBP1 mRNA | affects expression | 21346803
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of HSPBP1 mRNA | affects expression | 16483693
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of HSPBP1 protein | increases expression | 19072884
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
4.58 | 7525203 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.19 | 18287403 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.42 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.63 | 16712894 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
3.18 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
3.18 | 17306315 16507464 15276417 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.46 | 18572023 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
3.84 | 14694615 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
3.25 | 19524636 20056578 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
4.53 | 15095906 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.58 | 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
4.41 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
4.41 | 21346803 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
5.31 | 16452187 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.52 | 12676792 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.24 | 12646999 15346721 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
3.00 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
3.32 | 16705839 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
2.48 | 16712894 15276417 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.42 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
1.90 | 17306315 17077188 16712894 19931552 15276417 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.07 | 19082730 16487513 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.49 | 18551238 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
2.66 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
4.22 | 20056578 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.38 | 12854658 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
10.47 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
10.47 | 14694615 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.53 | 15276417 17306315 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.24 | 16039940 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.79 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
2.85 | 19524636 18572023 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
4.10 | 12854658 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.51 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
5.51 | 16452187 17306315 11723127 16712894 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.95 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
4.16 | 11813266 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
5.06 | 17056641 |
Pathway ID |
Pathway Name |
---|
KEGG:04141 |
Protein processing in endoplasmic reticulum |